Literature DB >> 24686256

Rescue transoesophageal echocardiography for refractory haemodynamic instability during transvenous lead extraction.

Jan N Hilberath1, Peter S Burrage2, Stanton K Shernan2, Dirk J Varelmann2, Kerry Wilusz2, John A Fox2, Holger K Eltzschig3, Laurence M Epstein4, Martina Nowak-Machen5.   

Abstract

AIMS: The rising number of cardiovascular implantable electronic devices has led to a steep increase in transvenous lead extractions (TLEs). Procedure-related, haemodynamically significant adverse events are uncommon during TLE yet remain an inevitable risk. While the use of transoesophageal echocardiography (TEE) as a guide to clinical decision-making during refractory circulatory instability has been well established, the specific utility of rescue TEE during TLE has not been comprehensively studied. METHODS AND
RESULTS: Twenty-six patients who required emergent TEE to determine the aetiology of intractable haemodynamic instability during TLE were evaluated. Pericardial effusion requiring urgent pericardiocentesis and/or cardiac surgical intervention was diagnosed by TEE in 10 patients, and progressed to cardiac arrest in 4 patients. Haemorrhagic shock developed in two patients suffering from femoral vein laceration and right haemothorax, respectively. One additional patient developed acute respiratory compromise and right ventricular dysfunction diagnosed by TEE, which necessitated prolonged post-operative intubation and inotropic therapy. In 14 patients, TEE excluded life-threatening cardiovascular injuries and enabled the pursuit of continued medical management. Two patients with reassuring TEE findings underwent intra-operative placement of chest tubes for pneumothorax. All the 26 patients were discharged from the hospital.
CONCLUSION: While TLE is a relatively safe procedure, life-threatening cardiovascular injuries remain a rare risk. In this study, the use of rescue TEE ruled out significant cardiovascular injuries in the majority of patients. Furthermore, rescue TEE had a substantial impact on the efficiency of determining the aetiology of refractory haemodynamic instability during TLE and thereby facilitated the timely initiation of definitive intervention. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  rescue echocardiography; resuscitation; transoesophageal echocardiography; transvenous lead extraction

Mesh:

Year:  2014        PMID: 24686256     DOI: 10.1093/ehjci/jeu043

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

1.  The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Andrzej Kleinrok; Łukasz Tułecki; Andrzej Kutarski
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

2.  Multiplane/3D transesophageal echocardiography monitoring to improve the safety and outcome of complex transvenous lead extractions.

Authors:  Mihai Strachinaru; Chris M Kievit; Sing C Yap; Alexander Hirsch; Marcel L Geleijnse; Tamas Szili-Torok
Journal:  Echocardiography       Date:  2019-03-24       Impact factor: 1.724

3.  "Ghost", a Well-Known but Not Fully Explained Echocardiographic Finding during Transvenous Lead Extraction: Clinical Significance.

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Łukasz Tułecki; Paweł Stefańczyk; Andrzej Kutarski
Journal:  Int J Environ Res Public Health       Date:  2022-10-01       Impact factor: 4.614

4.  Transesophageal Echocardiography As a Monitoring Tool During Transvenous Lead Extraction-Does It Improve Procedure Effectiveness?

Authors:  Dorota Nowosielecka; Wojciech Jacheć; Anna Polewczyk; Łukasz Tułecki; Konrad Tomków; Paweł Stefańczyk; Andrzej Tomaszewski; Wojciech Brzozowski; Dorota Szcześniak-Stańczyk; Andrzej Kleinrok; Andrzej Kutarski
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.